Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1698079

registered interest
date	22/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the guidance entitled 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth, published on 20 November 2023, what steps her Department is taking to apply the provisions of section 6.26 on exceptional circumstances.
tabling member constituency	Wythenshawe and Sale East
tabling member printed	Mike Kane
uin	20061
answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>In the vast majority of instances, payments required under the 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth will be affordable for companies, or can be mitigated by standard price increase processes. In exceptional circumstances only, the scheme allows companies to apply to increase their National Health Service list price, and for older medicines to reduce their top-up payment percentage, even when their wider portfolio is otherwise profitable. To qualify, a product must be demonstrably uneconomic to supply, there must be clear evidence that supply disruption would otherwise occur, and this disruption must have a negative impact on patients or the NHS. The Department already has processes and committees to consider applications for exceptional circumstances, established under previous pricing schemes.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20062 question first answered 15/04/2024 08:11:01 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4316 label Biography information for Mike Kane

1698080

registered interest
date	22/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to section 6.26 of the guidance entitled 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth, published on 20 November 2023, whether her Department has been allocated additional resources to consider exceptional circumstances.
tabling member constituency	Wythenshawe and Sale East
tabling member printed	Mike Kane
uin	20062
answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>In the vast majority of instances, payments required under the 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth will be affordable for companies, or can be mitigated by standard price increase processes. In exceptional circumstances only, the scheme allows companies to apply to increase their National Health Service list price, and for older medicines to reduce their top-up payment percentage, even when their wider portfolio is otherwise profitable. To qualify, a product must be demonstrably uneconomic to supply, there must be clear evidence that supply disruption would otherwise occur, and this disruption must have a negative impact on patients or the NHS. The Department already has processes and committees to consider applications for exceptional circumstances, established under previous pricing schemes.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20061 question first answered 15/04/2024 08:11:01 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4316 label Biography information for Mike Kane

1697839

registered interest
date	21/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Palliative Care: Children and Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if NHS England will (a) fund and (b) publish a data dashboard to help integrated care boards commission children and young people’s palliative and end of life care.
tabling member constituency	East Ham
tabling member printed	Sir Stephen Timms
uin	19763
answer	answer is ministerial correction date of answer 23/04/2024 answer text <p>NHS England has developed an all-age palliative and end of life care dashboard, which brings together all relevant local data in one place in an easily accessible format. The dashboard is accessible to integrated care boards (ICBs) and their commissioners and helps them understand the palliative and end of life care needs of their local population, including children and young people. This supports commissioners in their statutory duty for palliative and end of life care, enabling ICBs to put plans in place to address and track the improvement of health inequalities, and ensure that funding is distributed fairly based on prevalence.</p><p>Funding has been confirmed to ensure continued maintenance of the dashboard for 2024/25, with discussions ongoing regarding further development and use. There is, however, existing publicly available data, such as the Office for Health Improvement and Disparities ‘Fingertips’ data on palliative and end of life care.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 23/04/2024 12:47:06 answering member 4527 label Biography information for Helen Whately
tabling member	163 label Biography information for Sir Stephen Timms

1697850

registered interest
date	21/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Genetics: Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many patients in the South West have been eligible for pre-implantation genetic testing for monogenic disorders in each of the last five years.
tabling member constituency	Bristol East
tabling member printed	Kerry McCarthy
uin	19828
answer	answer is ministerial correction date of answer 16/04/2024 answer text <p>Pre-implantation Genetic Testing (PGT) is used to identify genetic anomalies in embryos created through in-vitro fertilisation. Over 600 genetic conditions can currently be tested for using this technique, as licensed by the Human Fertilisation and Embryology Authority. NHS England has commissioned five centres to provide PGT to patients in England. The number of PGT cycles undertaken has increased from 223 patients in 2009 to 620 in 2019, but NHS England does not have access to data that describes the geographical profile of the people that have used the National Health Service or privately commissioned PGT services.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/04/2024 10:39:37 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1491 label Biography information for Kerry McCarthy

1697081

registered interest
date	19/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Digital Technology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the annual budget for the NHS England Frontline Digitisation programme was (a) when that programme was established and (b) at the start of financial year (i) 2022-23, (ii) 2023-24 and (iii) 2024-25.
tabling member constituency	Ilford North
tabling member printed	Wes Streeting
uin	19411
answer	answer is ministerial correction date of answer 24/05/2024 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/05/2024 13:18:32 answering member 4044 label Biography information for Andrew Stephenson previous answer version 25894 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
tabling member	4504 label Biography information for Wes Streeting

1697083

registered interest
date	19/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Expenditure
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Answer of 12 October 2021 to Question 51702 on NHS: Expenditure, how much NHS England, clinical commissioning groups and integrated care boards spent in aggregate on (a) mental health services, (b) acute health services, (c) social care services, (d) primary medical services, (e) specialised services, (f) NHS continuing healthcare and (g) all other recorded spending categories in each financial year since 2015-16; and how much those organisations plan to spend in aggregate in each of those areas in the (i) 2023-24 and (ii) 2024-25 financial years.
tabling member constituency	Ilford North
tabling member printed	Wes Streeting
uin	19413
answer	answer is ministerial correction date of answer 01/05/2024 answer text <p>The information requested up to 2023/24 is in the attached table due to its size. NHS England continues to work with integrated care boards (ICB) to develop their financial plans for 2024/25. Until that process is complete, we will not have a final agreed set of financial plans for the year ahead.</p><p>The £38 billion increase in clinical commissioning group and ICB direct commissioning spend between the 2019/20 and 2023/24 budgets reflects the record settlement for health and social care funding confirmed at the 2021 Spending Review.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 01/05/2024 16:20:23 answering member 4044 label Biography information for Andrew Stephenson attachment 1 file name FORMATTED TABLE FOR MINISTERIAL CLEARANCE PQ19413 table.docx title PQ19413 Table previous answer version 25896 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
tabling member	4504 label Biography information for Wes Streeting

1696390

registered interest
date	15/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Frank Hester
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many contracts (a) the NHS and (b) her Department has with companies owned by Frank Hester.
tabling member constituency	Brent Central
tabling member printed	Dawn Butler
uin	18869
answer	answer is ministerial correction date of answer 24/05/2024 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/05/2024 13:13:32 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1489 label Biography information for Dawn Butler

1696391

registered interest
date	15/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Frank Hester
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the value is of her Department's contracts with companies owned by Frank Hester.
tabling member constituency	Brent Central
tabling member printed	Dawn Butler
uin	18870
answer	answer is ministerial correction date of answer 24/05/2024 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/05/2024 13:14:51 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1489 label Biography information for Dawn Butler

1696392

registered interest
date	15/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Frank Hester
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much money her Department paid to companies owned by Frank Hester in each of the last four years.
tabling member constituency	Brent Central
tabling member printed	Dawn Butler
uin	18871
answer	answer is ministerial correction date of answer 24/05/2024 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Dissolution.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/05/2024 13:58:45 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1489 label Biography information for Dawn Butler

1695785

registered interest
date	13/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Laboratories: Disease Control
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 8 March 2024 to Question 16313 on Laboratories: Disease Control, what the budget for the maintenance of Category 4 laboratories was for each of the last five years; and what funds have been allocated for such maintenance for the future.
tabling member constituency	West Suffolk
tabling member printed	Matt Hancock
uin	18425
answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>The UK Health Security Agency’s Porton Down and Colindale scientific campus sites do not have separate operational costs for the Category 4 laboratories. Spend on the maintenance and operation of these sites is provided through the spending review process.</p><p>Work is ongoing to establish the most robust approach for continued delivery of the high-quality science at Porton Down</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 18426 question first answered 15/04/2024 08:39:01 answering member 4492 label Biography information for Maria Caulfield
tabling member	4070 label Biography information for Matt Hancock